Aprotinin and sevoflurane do not affect renal function during single-ventricle palliative surgery [51]

Anesthesia and Analgesia

Volumn 103, Issue 6, 2006, Pages 1614-1615

  Skidmore, Kimberly L ^a   Azakie, Anthony ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CREATININE; MIDAZOLAM; OXYGEN; SEVOFLURANE;

CHILD; CLINICAL ARTICLE; CREATININE CLEARANCE; DOSE TIME EFFECT RELATION; FONTAN PROCEDURE; HEART SINGLE VENTRICLE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LETTER; LUNG PRESSURE; NEPHROTOXICITY; NORWOOD PROCEDURE; PALLIATIVE THERAPY; PRESSURE GRADIENT; PRIORITY JOURNAL; THROMBOSIS; TREATMENT OUTCOME;

APROTININ; CHILD; CHILD, PRESCHOOL; HEART VENTRICLES; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY; METHYL ETHERS; PALLIATIVE CARE; RETROSPECTIVE STUDIES;

EID: 33845609618     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000246392.57157.5a     Document Type: Letter

References (4)

1. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006;354:353-65.
2. Alexi-Meskishvilli V, Stiller B, Koster A, et al. Correction of congenital heart defects in Jehovah's Witness children. Thorac Cardiovasc Surg 2004;52:141-6.
3. Tweddell JS, Berger S, Frommelt PC, et al. Aprotinin improves outcome of single ventricle palliation. Ann Thorac Surg 1996;62:1329-35.
4. Shiga T, Wajima Z, Inoue T, Sakamoto A. Aprotinin in major orthopedic surgery: a systematic review of randomized controlled trials. Anesth Analg 2005;101:1602-7.